ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

10x Genomics, Inc. (TXG)

NASDAQ

$17.51

$-1.64

(-8.56%)

10x Genomics, Inc. (TXG) Live Price Chart

Page last updated: 2026-02-12 21:26:00

Key Market Data

Market Cap	$2.04B
Open	$19.00
High	$208.99
Low	$6.78
Previous Close	$19.15
Price Change	$-1.64
Percentage Change	-8.56%
Volume	4M

10x Genomics, Inc. (TXG) Stock Price Today

10x Genomics, Inc. (TXG) is currently trading at $17.51 as of 2026-02-12 21:26:00, reflecting a -8.56% move ($-1.64) from the previous close.

In the short term, the stock has returned -1,630.02% over the past four weeks. Over the last 12 months, 10x Genomics, Inc. has recorded a +45.92% price change, indicating a strong performance relative to the broader market.

10x Genomics, Inc. (TXG) 7-Day Stock Price Changes

Over the past seven days, 10x Genomics, Inc. has traded within a short-term range shaped by market sentiment in the LABORATORY ANALYTICAL INSTRUMENTS sector. During this period, the stock moved from its previous closing price of $18.32 to the latest recorded price of $17.51, reflecting an intraday change of -8.56%. Daily movements highlight shifts in trading volume (3,630,589), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, TXG has delivered a -1,630.02% return over the past month and a +45.92% change in the last 12 months, indicating a strong trend relative to its broader sector peers.

How to Buy 10x Genomics, Inc. (TXG)

You can buy and trade TXG on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for TXG and Execute Your Trade

Open the trading page, enter TXG in the search bar, select the amount of TXG you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is 10x Genomics, Inc. (TXG)?

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

10x Genomics, Inc. Information

Industry	LABORATORY ANALYTICAL INSTRUMENTS
Employees	1,306
Sector	LABORATORY ANALYTICAL INSTRUMENTS
Company Website	https://www.10xgenomics.com

Frequently Asked Questions (FAQ)

1.What is the current share price of 10x Genomics, Inc.?

The latest trading price for 10x Genomics, Inc. (Common Stock) is $ 17.51, compared with a previous closing price of $ 19.15. That means the stock has moved -8.56% so far today. Intraday price updates and recent trading activity for TXG can be tracked on the live chart and quote section on this page.

2.Is 10x Genomics, Inc. stock going up or down?

Looking at recent performances, TXG has returned -1,630.02% over the past month, +30.09% over the last six months and +45.92% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe strong price momentum for 10x Genomics, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does TXG currently sit relative to its 52-week high and low?

In the most recent 52-week period, 10x Genomics, Inc. has traded between a low of $ 6.78 and a high of $ 23.56. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether TXG is currently nearer the top or the bottom of its one-year trading band.

4.How is 10x Genomics, Inc. classified by sector and industry?

10x Genomics, Inc. is classified in the LABORATORY ANALYTICAL INSTRUMENTS sector. In practice, this means 10x Genomics, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing TXG’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the LABORATORY ANALYTICAL INSTRUMENTS sector could influence 10x Genomics, Inc.’s performance.

5.Where is 10x Genomics, Inc. listed and how large is it by market value?

10x Genomics, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 2.04B, the company is classified as a Mid-cap stock. Market cap gives a quick sense of 10x Genomics, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does TXG's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -0.60 summarises how much profit 10x Genomics, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track 10x Genomics, Inc.'s financial performance over time?

To follow 10x Genomics, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how TXG is performing and how the market is responding.

8.When is 10x Genomics, Inc. expected to report earnings?

10x Genomics, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for TXG, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in 10x Genomics, Inc.'s earnings reports?

10x Genomics, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether TXG is meeting, beating or missing expectations.

10.How can I stay informed about 10x Genomics, Inc.'s results and guidance?

You can stay up to date on 10x Genomics, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for TXG on this page helps you see how new information is being reflected in the stock.

11.Does 10x Genomics, Inc. pay a regular cash dividend to its shareholders?

10x Genomics, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor TXG's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for TXG?

Based on the latest earnings data, TXG has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether 10x Genomics, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings 10x Genomics, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is 10x Genomics, Inc.?

10x Genomics, Inc. is a publicly traded company in the LABORATORY ANALYTICAL INSTRUMENTS industry within the LABORATORY ANALYTICAL INSTRUMENTS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is TXG valued in terms of P/E ratio and EPS?

10x Genomics, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.60. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of 10x Genomics, Inc.'s earnings. Comparing TXG's P/E and EPS to those of other LABORATORY ANALYTICAL INSTRUMENTS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as 10x Genomics, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Coterra Energy Inc.

CTRA

Delta Air Lines, Inc.

DAL

Edison International

EIX

Flutter Entertainment plc

FLUT

JPMorgan Chase & Co.

JPM

Top Gainers

Browse today's leading gainers in the US stock market

Haoxin Holdings Limited

HXHX

IPG Photonics Corporation

IPGP

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

TXG-to-USD Calculator

Amount

TXG

USD

1 TXG = 17.51 USD